Pre-pre-B acute lymphoblastic leukemia: high frequency of alternatively spliced ALL1-AF4 transcripts and absence of minimal residual disease during complete remission - PubMed (original) (raw)
. 1994 Dec 1;84(11):3835-42.
Affiliations
- PMID: 7949140
Free article
Pre-pre-B acute lymphoblastic leukemia: high frequency of alternatively spliced ALL1-AF4 transcripts and absence of minimal residual disease during complete remission
J W Janssen et al. Blood. 1994.
Free article
Abstract
We used the polymerase chain reaction (PCR) to detect ALL1-AF4 rearrangements, the molecular hallmark of t(4;11) in a series of 46 pre-pre-B (CD19+, CD24+, CD10/CD20/cylgM/sIgM-) acute lymphoblastic leukemias (ALL). Eighteen patients (39%) exhibited fusion transcripts including 4 of 12 children and 14 of 34 adults. This genetic defect was associated with hyperleukocytosis (median leukocyte count 176 x 10(9)/L) and expression of myeloid-associated antigens (CDw65+). In contrast, only two patients from a group of 67 common (CD19/CD10+, cylgM/sIgM-) and pre-B ALLs (CD19/cylgM+, CD10 +/-, sIgM-) showed ALL1-AF4 mRNA. All PCR-positive cases showed multiple amplification products representing alternative splicing events. Moreover, reciprocal der (4)-derived AF4-ALL1 transcripts were observed in 65% of the cases analyzed. Eight of the 18 pre-pre-B ALL patients with an ALL1-AF4 recombination are currently in complete continuous remission for up to 54 months (median, 26 months). Twelve remission samples were available from seven cases, and all of them lacked evidence of minimal residual disease. Overall this study documents a similarly high incidence of ALL1-AF4 recombinations in children (infants excluded) and adults with pre-pre-B ALL and demonstrates the decline of the leukemic cell clone below the detection level of PCR in a remarkable proportion of patients under intense treatment protocols.
Similar articles
- Myeloperoxidase gene expression in non-infant pro-B acute lymphoblastic leukaemia with or without ALL1/AF4 transcript.
Serrano J, Lo Coco F, Sprovieri T, Elia L, Vitale A, Gregorj C, Tafuri A, Sánchez J, Román J, Torres A, Cimino G. Serrano J, et al. Br J Haematol. 2000 Dec;111(4):1065-70. doi: 10.1046/j.1365-2141.2000.02484.x. Br J Haematol. 2000. PMID: 11167741 - Molecular analysis of t(11;19) breakpoints in childhood acute leukemias.
Rubnitz JE, Behm FG, Curcio-Brint AM, Pinheiro RP, Carroll AJ, Raimondi SC, Shurtleff SA, Downing JR. Rubnitz JE, et al. Blood. 1996 Jun 1;87(11):4804-8. Blood. 1996. PMID: 8639852 - Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias.
Cimino G, Rapanotti MC, Biondi A, Elia L, Lo Coco F, Price C, Rossi V, Rivolta A, Canaani E, Croce CM, Mandelli F, Greaves M. Cimino G, et al. Cancer Res. 1997 Jul 15;57(14):2879-83. Cancer Res. 1997. PMID: 9230194 - ALL1 gene alterations in acute leukemia: biological and clinical aspects.
Cimino G, Rapanotti MC, Sprovieri T, Elia L. Cimino G, et al. Haematologica. 1998 Apr;83(4):350-7. Haematologica. 1998. PMID: 9592986 Review. - Self-fusion of the ALL1 gene. A new genetic mechanism for acute leukemia.
Schichman SA, Canaani E, Croce CM. Schichman SA, et al. JAMA. 1995 Feb 15;273(7):571-6. JAMA. 1995. PMID: 7837391 Review. No abstract available.
Cited by
- The RS4;11 cell line as a model for leukaemia with t(4;11)(q21;q23): Revised characterisation of cytogenetic features.
Ragusa D, Makarov EM, Britten O, Moralli D, Green CM, Tosi S. Ragusa D, et al. Cancer Rep (Hoboken). 2019 Oct;2(5):e1207. doi: 10.1002/cnr2.1207. Epub 2019 Aug 7. Cancer Rep (Hoboken). 2019. PMID: 32721124 Free PMC article. - HOXA9 is required for survival in human MLL-rearranged acute leukemias.
Faber J, Krivtsov AV, Stubbs MC, Wright R, Davis TN, van den Heuvel-Eibrink M, Zwaan CM, Kung AL, Armstrong SA. Faber J, et al. Blood. 2009 Mar 12;113(11):2375-85. doi: 10.1182/blood-2007-09-113597. Epub 2008 Dec 3. Blood. 2009. PMID: 19056693 Free PMC article. - B-cell acute lymphoblastic leukemia with t(4;11)(q21;q23) in a young woman: evolution into mixed phenotype acute leukemia with additional chromosomal aberrations in the course of therapy.
Carulli G, Marini A, Ferreri MI, Azzarà A, Ottaviano V, Lari T, Rocco M, Giuntini S, Petrini M. Carulli G, et al. Hematol Rep. 2012 Jul 11;4(3):e15. doi: 10.4081/hr.2012.e15. Epub 2012 Sep 6. Hematol Rep. 2012. PMID: 23087804 Free PMC article.